These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19187965)

  • 1. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
    Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
    Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
    Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ
    Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
    Kulik L; Chen K; Huber BT; Holers VM
    Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
    Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
    Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
    J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function.
    Marchbank KJ; Watson CC; Ritsema DF; Holers VM
    J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.
    Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ
    Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
    Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
    J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
    Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
    J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
    Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
    Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.
    Isnardi I; Ng YS; Menard L; Meyers G; Saadoun D; Srdanovic I; Samuels J; Berman J; Buckner JH; Cunningham-Rundles C; Meffre E
    Blood; 2010 Jun; 115(24):5026-36. PubMed ID: 20231422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.
    Pappworth IY; Hayes C; Dimmick J; Morgan BP; Holers VM; Marchbank KJ
    Immunobiology; 2012 Feb; 217(2):147-57. PubMed ID: 21783272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.
    Booker JK; Reap EA; Cohen PL
    J Immunol; 1998 Nov; 161(9):4536-41. PubMed ID: 9794379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells.
    Rathmell JC; Goodnow CC
    J Immunol; 1994 Sep; 153(6):2831-42. PubMed ID: 8077685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.
    Quách TD; Manjarrez-Orduño N; Adlowitz DG; Silver L; Yang H; Wei C; Milner EC; Sanz I
    J Immunol; 2011 Apr; 186(8):4640-8. PubMed ID: 21398610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation.
    Kozono Y; Kotzin BL; Holers VM
    J Immunol; 1996 Jun; 156(11):4498-503. PubMed ID: 8666826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes.
    Rubio CF; Kench J; Russell DM; Yawger R; Nemazee D
    J Immunol; 1996 Jul; 157(1):65-71. PubMed ID: 8683157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.